ריוולושיין וטרינרי % 12
zoetis israel holding b.v., israel - selamectin - תמיסה - selamectin 120 mg/ml
בטאקלציפ טבע
teva israel ltd - betamethasone as dipropionate; calcipotriol - משחה - calcipotriol 50 mcg / 1 g; betamethasone as dipropionate 0.5 mg / 1 g - calcipotriol, combinations
איסדרם וטרינרי
vetmarket ltd, israel - betamethasone as valerate; fusidic acid as hemihydrate - ג'ל - betamethasone as valerate 0.1 %; fusidic acid as hemihydrate 0.5 %
יאז פלוס
bayer israel ltd - drospirenone; ethinylestradiol as betadex clathrate; levomefolate calcium; levomefolate calcium - טבליות מצופות פילם - levomefolate calcium 0.451 mg; ethinylestradiol as betadex clathrate 0.02 mg; drospirenone 3 mg; levomefolate calcium 0.451 mg - estradiol, combinations
לוטן 100
unipharm ltd, israel - losartan potassium - טבליה - losartan potassium 100 mg - losartan
לוטן 12.5
unipharm ltd, israel - losartan potassium - טבליה - losartan potassium 12.5 mg - losartan
לוטן 50
unipharm ltd, israel - losartan potassium - טבליה - losartan potassium 50 mg - losartan
רקורמון 2000 iu
roche pharmaceuticals (israel) ltd - epoetin beta 2000 iu / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative
רקורמון iu 3000
roche pharmaceuticals (israel) ltd - epoetin beta 3000 iu / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative
מירסרה 30 מק"ג/0.3 מ"ל
roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta 30 mcg/ml / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic kidney disease (ckd).